Y Zhang,
Z Xu,
H Quan, J Lin - arXiv preprint arXiv:2302.04777, 2023 - arxiv.org
The primary objective of phase I oncology studies is to establish the safety profile of a new
treatment and determine the maximum tolerated dose (MTD). This is motivated by the …